Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS April Town Hall Gives Firms Forum To Weigh In On OPPS 2003 Update

This article was originally published in The Gray Sheet

Executive Summary

AdvaMed plans to use its allotted speaking time during an April 5 CMS town hall meeting on Medicare's outpatient prospective payment system (OPPS) to offer suggestions for the 2003 update

You may also be interested in...



Brachytherapy Seed Manufacturers Rally For Discrete OPPS Payment Codes

Medicare should accommodate the variability in prices of radioactive sources when transitioning brachytherapy "pass-through" device costs into the ambulatory payment classification (APC) pool, industry reps testified April 5 at CMS' Baltimore "town hall" meeting on the OPPS update for 2003

Brachytherapy Seed Manufacturers Rally For Discrete OPPS Payment Codes

Medicare should accommodate the variability in prices of radioactive sources when transitioning brachytherapy "pass-through" device costs into the ambulatory payment classification (APC) pool, industry reps testified April 5 at CMS' Baltimore "town hall" meeting on the OPPS update for 2003

Medicare Revisits “New Technology” Outpatient Payment Levels For 2002

FDG-PET will be reimbursed at $1,375 per procedure under CMS' hospital outpatient prospective payment system update for 2002. The payment rate will go into effect April 1

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016286

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel